The Drug Controller General of India on Sunday granted permission to the Serum Institute of India in Pune to conduct phase two and three human clinical trials of the coronavirus vaccine candidate developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca, PTI reported. Read the full story at Scroll.in
CMC Vellore Gets Simulation Lab to Train Doctors, Nurses in Maternal and Neonatal Care
January 23, 2023
The lab has been set up by the U.S. Agency for International Development, supported by a USD 1 million grant; it aims at reducing maternal, newborn and child mortality and
